Keywords: fda, committee, gives, nod, glaxo, otc, zantac
FDA Committee Gives Nod To Glaxo's OTC Zantac
Article | 24 July 1995
A US Food and Drug Administration advisory committee has recommended approval for an over-the-counter version of Glaxo's antiulcerant Zantac (ranitidine). ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
